ADULT GROWTH HORMONE DEFICIENCY
Clinical trials for ADULT GROWTH HORMONE DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new ADULT GROWTH HORMONE DEFICIENCY trials appear
Sign up with your email to follow new studies for ADULT GROWTH HORMONE DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weekly shot could replace daily hormone injections for adults
Disease control CompletedThis study tests a new once-weekly growth hormone injection (ACP-001) in adults with growth hormone deficiency. It compares three different doses of the weekly shot against a standard daily growth hormone product over four weeks. The goal is to see if the weekly injection is safe…
Matched conditions: ADULT GROWTH HORMONE DEFICIENCY
Phase: PHASE2 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Weekly shot shows promise for adult growth hormone deficiency in Long-Term trial
Disease control CompletedThis study tested a once-weekly injection called lonapegsomatropin in 220 adults with growth hormone deficiency who had already completed a previous trial. The goal was to see if the drug remains safe and effective over a full year. Participants received the injection for 52 week…
Matched conditions: ADULT GROWTH HORMONE DEFICIENCY
Phase: PHASE3 • Sponsor: Ascendis Pharma Endocrinology Division A/S • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC